Handbook of Methods for Designing, Monitoring, and Analyzing Dose-Finding Trials
Herausgeber: O'Quigley, John; Bornkamp, Björn; Iasonos, Alexia
Handbook of Methods for Designing, Monitoring, and Analyzing Dose-Finding Trials
Herausgeber: O'Quigley, John; Bornkamp, Björn; Iasonos, Alexia
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
"A CRC title, part of the Taylor & Francis imprint, a member of the Taylor & Francis Group, the academic division of T&F Informa plc."
Andere Kunden interessierten sich auch für
- Ying YuanBayesian Designs for Phase I-II Clinical Trials88,99 €
- Quantitative Drug Safety and Benefit Risk Evaluation46,99 €
- Arul EarnestEssentials of a Successful Biostatistical Collaboration113,99 €
- Richard J. HayesCluster Randomised Trials152,99 €
- Bayesian Methods in Pharmaceutical Research64,99 €
- Value of Information for Healthcare Decision-Making139,99 €
- Ram TiwariSignal Detection for Medical Scientists63,99 €
-
-
-
"A CRC title, part of the Taylor & Francis imprint, a member of the Taylor & Francis Group, the academic division of T&F Informa plc."
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Chapman & Hall/CRC Handbooks of Modern Statistical Methods
- Verlag: Taylor & Francis Inc
- Seitenzahl: 320
- Erscheinungstermin: 25. April 2017
- Englisch
- Abmessung: 251mm x 183mm x 23mm
- Gewicht: 804g
- ISBN-13: 9781498746106
- ISBN-10: 1498746101
- Artikelnr.: 48453806
- Chapman & Hall/CRC Handbooks of Modern Statistical Methods
- Verlag: Taylor & Francis Inc
- Seitenzahl: 320
- Erscheinungstermin: 25. April 2017
- Englisch
- Abmessung: 251mm x 183mm x 23mm
- Gewicht: 804g
- ISBN-13: 9781498746106
- ISBN-10: 1498746101
- Artikelnr.: 48453806
O'Quigley, John; Iasonos, Alexia; Bornkamp, Björn
Part I. Introduction to the objectives of Phase I studies and endpoints.
Overview of Phase I designs. Model based designs when safety is the primary
aim. Using non binary endpoints. Dose expansion cohorts. Part II. Safety
and Efficacy: bivariate endpoints. Combination studies. Studies with
multiple schedules. Studies in the presence of patient heterogeneity.
Pediatrics. Parameterization: model complexity and optimal designs. Part
III. Dose-Finding Trials in Phase II-Overview and Objectives. Analysis of
Confirmatory Dose-Finding Studies. Design of dose-finding trials: Doses,
allocation weights and sample size. The MCP-Mod methodology: Practical
Considerations and the DoseFinding R package. Two-stage designs for
dose-finding studies. Longitudinal approaches for dose-response modelling.
Regulatory Viewpoint on Dose-Finding Studies. Part IV. Introduction to
Pharmacometrics: Exposure Response Modeling. Pharmacokinetic Data
Structure. Pharmacokinetic Compartment Modeling. Approximate Likelihood
Approaches for Pharmacometrics. Population Pharmacokinetics.
Pharmacodynamic Models Bayesian Approaches for Pharmacometric Modeling.
Pharmacometrics Modeling Examples.
Overview of Phase I designs. Model based designs when safety is the primary
aim. Using non binary endpoints. Dose expansion cohorts. Part II. Safety
and Efficacy: bivariate endpoints. Combination studies. Studies with
multiple schedules. Studies in the presence of patient heterogeneity.
Pediatrics. Parameterization: model complexity and optimal designs. Part
III. Dose-Finding Trials in Phase II-Overview and Objectives. Analysis of
Confirmatory Dose-Finding Studies. Design of dose-finding trials: Doses,
allocation weights and sample size. The MCP-Mod methodology: Practical
Considerations and the DoseFinding R package. Two-stage designs for
dose-finding studies. Longitudinal approaches for dose-response modelling.
Regulatory Viewpoint on Dose-Finding Studies. Part IV. Introduction to
Pharmacometrics: Exposure Response Modeling. Pharmacokinetic Data
Structure. Pharmacokinetic Compartment Modeling. Approximate Likelihood
Approaches for Pharmacometrics. Population Pharmacokinetics.
Pharmacodynamic Models Bayesian Approaches for Pharmacometric Modeling.
Pharmacometrics Modeling Examples.
Part I. Introduction to the objectives of Phase I studies and endpoints.
Overview of Phase I designs. Model based designs when safety is the primary
aim. Using non binary endpoints. Dose expansion cohorts. Part II. Safety
and Efficacy: bivariate endpoints. Combination studies. Studies with
multiple schedules. Studies in the presence of patient heterogeneity.
Pediatrics. Parameterization: model complexity and optimal designs. Part
III. Dose-Finding Trials in Phase II-Overview and Objectives. Analysis of
Confirmatory Dose-Finding Studies. Design of dose-finding trials: Doses,
allocation weights and sample size. The MCP-Mod methodology: Practical
Considerations and the DoseFinding R package. Two-stage designs for
dose-finding studies. Longitudinal approaches for dose-response modelling.
Regulatory Viewpoint on Dose-Finding Studies. Part IV. Introduction to
Pharmacometrics: Exposure Response Modeling. Pharmacokinetic Data
Structure. Pharmacokinetic Compartment Modeling. Approximate Likelihood
Approaches for Pharmacometrics. Population Pharmacokinetics.
Pharmacodynamic Models Bayesian Approaches for Pharmacometric Modeling.
Pharmacometrics Modeling Examples.
Overview of Phase I designs. Model based designs when safety is the primary
aim. Using non binary endpoints. Dose expansion cohorts. Part II. Safety
and Efficacy: bivariate endpoints. Combination studies. Studies with
multiple schedules. Studies in the presence of patient heterogeneity.
Pediatrics. Parameterization: model complexity and optimal designs. Part
III. Dose-Finding Trials in Phase II-Overview and Objectives. Analysis of
Confirmatory Dose-Finding Studies. Design of dose-finding trials: Doses,
allocation weights and sample size. The MCP-Mod methodology: Practical
Considerations and the DoseFinding R package. Two-stage designs for
dose-finding studies. Longitudinal approaches for dose-response modelling.
Regulatory Viewpoint on Dose-Finding Studies. Part IV. Introduction to
Pharmacometrics: Exposure Response Modeling. Pharmacokinetic Data
Structure. Pharmacokinetic Compartment Modeling. Approximate Likelihood
Approaches for Pharmacometrics. Population Pharmacokinetics.
Pharmacodynamic Models Bayesian Approaches for Pharmacometric Modeling.
Pharmacometrics Modeling Examples.